A framework for the definition and interpretation of the use of surrogate endpoints in interventional trialsOriana Ciani, Rod S Taylor, Dalia Dawoud et al.|EClinicalMedicine|2023Cited by 60
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Oriana Ciani, Philippa Davies et al.|BMJ|2024Cited by 45
Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Oriana Ciani, Philippa Davies et al.|BMJ|2024Cited by 28
Orbitofrontal<sup><b>18</b></sup>F-DOPA Uptake and Movement Preparation in Parkinson’s DiseaseLucio Marinelli, Flavio Nobili|Parkinson s Disease|2015Cited by 8
A Framework for the Definition and Interpretation of the Use of Surrogate Endpoints in Interventional Trials’Oriana Ciani, Rod S Taylor, Anthony Muchai Manyara et al.|SSRN Electronic Journal|2023Cited by 0